Quarterly report pursuant to Section 13 or 15(d)

Avinza Co-Promotion (Tables)

v2.4.0.8
Avinza Co-Promotion (Tables)
3 Months Ended
Mar. 31, 2014
Co Promotion [Abstract]  
Summary of co-promote termination liability
A summary of the co-promote termination liability as of March 31, 2014 is as follows (in thousands):

Net present value of payments based on estimated future net Avinza product sales as of December 31, 2013
$
11,746

Assumed payments made by Pfizer or assignee
(276
)
Fair value adjustments
(10,334
)
Total co-promote termination liability as of March 31, 2014
1,136

Less: current portion of co-promote termination liability as of March 31, 2014
688

Long-term portion of co-promote termination liability as of March 31, 2014
$
448